Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Rümke

Showing results (21-30 of 43) with videos related to

Pageof 5
Sort By:
Clinical and Experimental Immunology|April 1, 1976
Histone and DNA detection in swollen spermatozoa and somatic cells, by immunofluorescenceT Smauel, A H Kolk, P Rümke, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 1, 1986
Combined treatment with radiation and hyperthermia in metastatic malignant melanomaD Gonzalez Gonzalez, J D van Dijk, L E Blank, et al.
European Journal of Cancer & Clinical Oncology|August 1, 1982
N-(phosphonacetyl)-L-aspartate (PALA) in advanced malignant melanoma: a phase II trial of the EORTC Malignant Melanoma Cooperative GroupU R Kleeberg, J H Mulder, P Rümke, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Long-term adjuvant immunotherapy in stage I high risk malignant melanoma, comparing two BCG preparations versus non-treatment in a randomised multicentre study (EORTC Protocol 18781)B M Czarnetzki, E Macher, S Suciu, et al.
International Journal of Cancer|December 15, 1975
Antibodies and antigen expression in human melanoma detected by the immune adherence testS Cornain, J E de Vries, J Collard, et al.
Leukemia Research|January 1, 1984
Prevalence of HTLV-specific antibodies in Surinam emigrants to The NetherlandsM Robert-Guroff, R A Coutinho, A W Zadelhoff, et al.
International Journal of Cancer|March 15, 1985
Biochemical characterization and cellular localization of a formalin-resistant melanoma-associated antigen reacting with monoclonal antibody NKI/C-3C Vennegoor, J Calafat, P Hageman, et al.
International Journal of Cancer|September 15, 1983
Antibodies against human T-cell leukemia/lymphoma virus (HTLV) and expression of HTLV p19 antigen in relatives of a T-cell leukemia patient originating from SurinamF A Vyth-Dreese, P Rümke, M Robert-Guroff, et al.
International Journal of Cancer|November 15, 1981
Adjuvant reactivity predicts survival in patients with "high-risk" primary malignant melanoma treated with systemic BCG. EORTC Malignant Melanoma Cooperative Group Writing CommitteeA J Cochran, M E Buyse, F J Lejeune, et al.
Surgery, Gynecology & Obstetrics|July 1, 1988
Results of radical dissection of the groin in patients with stage II melanoma and histologically proved metastases of the iliac or obturator lymph nodes, or bothA Jonk, B B Kroon, P Rümke, et al.
Pageof 5

Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
Clinical and Experimental Immunology|April 1, 1976
Histone and DNA detection in swollen spermatozoa and somatic cells, by immunofluorescenceT Smauel, A H Kolk, P Rümke, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 1, 1986
Combined treatment with radiation and hyperthermia in metastatic malignant melanomaD Gonzalez Gonzalez, J D van Dijk, L E Blank, et al.
European Journal of Cancer & Clinical Oncology|August 1, 1982
N-(phosphonacetyl)-L-aspartate (PALA) in advanced malignant melanoma: a phase II trial of the EORTC Malignant Melanoma Cooperative GroupU R Kleeberg, J H Mulder, P Rümke, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Long-term adjuvant immunotherapy in stage I high risk malignant melanoma, comparing two BCG preparations versus non-treatment in a randomised multicentre study (EORTC Protocol 18781)B M Czarnetzki, E Macher, S Suciu, et al.
International Journal of Cancer|December 15, 1975
Antibodies and antigen expression in human melanoma detected by the immune adherence testS Cornain, J E de Vries, J Collard, et al.
Leukemia Research|January 1, 1984
Prevalence of HTLV-specific antibodies in Surinam emigrants to The NetherlandsM Robert-Guroff, R A Coutinho, A W Zadelhoff, et al.
International Journal of Cancer|March 15, 1985
Biochemical characterization and cellular localization of a formalin-resistant melanoma-associated antigen reacting with monoclonal antibody NKI/C-3C Vennegoor, J Calafat, P Hageman, et al.
International Journal of Cancer|September 15, 1983
Antibodies against human T-cell leukemia/lymphoma virus (HTLV) and expression of HTLV p19 antigen in relatives of a T-cell leukemia patient originating from SurinamF A Vyth-Dreese, P Rümke, M Robert-Guroff, et al.
International Journal of Cancer|November 15, 1981
Adjuvant reactivity predicts survival in patients with "high-risk" primary malignant melanoma treated with systemic BCG. EORTC Malignant Melanoma Cooperative Group Writing CommitteeA J Cochran, M E Buyse, F J Lejeune, et al.
Surgery, Gynecology & Obstetrics|July 1, 1988
Results of radical dissection of the groin in patients with stage II melanoma and histologically proved metastases of the iliac or obturator lymph nodes, or bothA Jonk, B B Kroon, P Rümke, et al.
Pageof 5